Table 1 Baseline clinical characteristics of subjects in MOS and MDC-CC
From: Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease
MOS | MDC-CC | |||
|---|---|---|---|---|
N | Mean (SD) | N | Mean (SD) | |
Age (years) | 1221 | 41.62 ± 13.6 | 553 | 59.16 ± 5.8 |
Women (%) | 1221 | 51.8 | 553 | 51.2 |
BMI (kg/m2) | 1221 | 26.04 ± 4.68 | 553 | 27.06 ± 4.56 |
Waist circumference (cm) | 1221 | 90 ± 14 | 553 | 89 ± 14 |
Fasting glucose (mmol/L) | 1219 | 5.48 ± 0.96 | 533 | 5.37 ± 1.26 |
LDL cholesterol (mmol/L) | 1217 | 3.21 ± 1.02 | 553 | 4.27 ± 0.92 |
HDL cholesterol (mmol/L) | 1218 | 1.6 ± 0.48 | 553 | 1.29 ± 0.33 |
Triglycerides (mmol/L) | 1208 | 1.17 ± 0.70 | 553 | 1.47 ± 0.70 |
Systolic blood pressure (mmHG) | 1165 | 120.62 ± 17.33 | 553 | 147.69 ± 19.97 |
Diastolic blood pressure (mmHG) | 1165 | 83.33 ± 10.71 | 553 | 89.72 ± 9.57 |